TY - JOUR
T1 - Factor analysis in predominantly severe COPD
T2 - Identification of disease heterogeneity by easily measurable characteristics
AU - Postma, Dirkje S.
AU - Anzueto, Antonio R.
AU - Jenkins, Christine
AU - Make, Barry J.
AU - Similowski, Thomas
AU - Östlund, Ollie
AU - Eriksson, Göran S.
AU - Calverley, Peter M.
N1 - Funding Information:
AstraZeneca, the study sponsor, was involved in the statistical data analysis, writing and revision of this manuscript, and the final decision to submit for publication. The authors thank Malin Fagerås and Anders Persson of AstraZeneca R&D, Mölndal, Sweden, for their assistance with the development of this manuscript and additional statistical analyses, respectively. Anna Mett and Natasha Hausman of inScience Communications, Springer Healthcare, provided editorial assistance (funded by AstraZeneca ).
PY - 2013/12
Y1 - 2013/12
N2 - Background The clinical and demographic variables defining the heterogeneity of chronic obstructive pulmonary disease (COPD) are unclear. A post-hoc analysis of five randomised studies in patients with a history of previous exacerbations examined the clinical and demographic characteristics describing moderate-to-very-severe COPD. Methods Factor analysis was performed on all continuous baseline demographic and clinical data, without variable selection. Analyses were based on the full cohort and on stratifications by pack-years smoked, smoking status, gender, and comorbidities; patient exacerbation history was analysed in two of the five studies. Findings 6162 COPD patients were evaluated (70% male; 40% current smokers; mean pre-bronchodilator forced expiratory volume in 1 s [FEV1] 35.2% predicted). Baseline clinical and demographic variables loaded differentially on six factors with minimal overlap, explaining 60.4% of the heterogeneity: 1) symptoms (cough, dyspnoea, sleep disturbance), health status, reliever use; 2) pre-bronchodilator FEV1, FEV1/forced vital capacity, morning peak expiratory flow (PEF), body mass index (BMI); 3) blood pressure; 4) age, months since first COPD symptoms; 5) PEF variability; 6) pulse, FEV1 reversibility. Most factors loaded similarly in stratified and exacerbation analyses. BMI loaded with reversibility in females, and with age and months since first COPD symptoms in ex-smokers. Exacerbations loaded to factor 6. Interpretation Readily available data can explain ∼60% of COPD heterogeneity in a large dataset of predominantly severe COPD patients. Factors were robust over determinants of disease outcome; gender, smoking status, pack-years smoked, and comorbidities. The main factors were largely unchanged by adding exacerbations. Only BMI loaded to other factors.
AB - Background The clinical and demographic variables defining the heterogeneity of chronic obstructive pulmonary disease (COPD) are unclear. A post-hoc analysis of five randomised studies in patients with a history of previous exacerbations examined the clinical and demographic characteristics describing moderate-to-very-severe COPD. Methods Factor analysis was performed on all continuous baseline demographic and clinical data, without variable selection. Analyses were based on the full cohort and on stratifications by pack-years smoked, smoking status, gender, and comorbidities; patient exacerbation history was analysed in two of the five studies. Findings 6162 COPD patients were evaluated (70% male; 40% current smokers; mean pre-bronchodilator forced expiratory volume in 1 s [FEV1] 35.2% predicted). Baseline clinical and demographic variables loaded differentially on six factors with minimal overlap, explaining 60.4% of the heterogeneity: 1) symptoms (cough, dyspnoea, sleep disturbance), health status, reliever use; 2) pre-bronchodilator FEV1, FEV1/forced vital capacity, morning peak expiratory flow (PEF), body mass index (BMI); 3) blood pressure; 4) age, months since first COPD symptoms; 5) PEF variability; 6) pulse, FEV1 reversibility. Most factors loaded similarly in stratified and exacerbation analyses. BMI loaded with reversibility in females, and with age and months since first COPD symptoms in ex-smokers. Exacerbations loaded to factor 6. Interpretation Readily available data can explain ∼60% of COPD heterogeneity in a large dataset of predominantly severe COPD patients. Factors were robust over determinants of disease outcome; gender, smoking status, pack-years smoked, and comorbidities. The main factors were largely unchanged by adding exacerbations. Only BMI loaded to other factors.
KW - Chronic obstructive pulmonary disease
KW - Exacerbations
KW - Factor analysis
KW - Heterogeneity
UR - http://www.scopus.com/inward/record.url?scp=84890313666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890313666&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2013.07.011
DO - 10.1016/j.rmed.2013.07.011
M3 - Article
C2 - 23953956
AN - SCOPUS:84890313666
SN - 0954-6111
VL - 107
SP - 1939
EP - 1947
JO - Respiratory Medicine
JF - Respiratory Medicine
IS - 12
ER -